Eplerenone

Eplerenone was developed by Pharmacia Corporation , which was acquired by Pfizer in 2002. [5] It was marketed by Pfizer under the trade name Inspra . The US Food and Drug Administration (FDA) approved the drug for sale in the United States in 2002. [5] Eplerenone is currently approved for sale in the US, EU, Netherlands and Japan. [5] Relative to dosage, eplerenone costs an estimated $2.93 per day when treating congestive heart failure and $5.86 per day when treating hypertension . [6]

"Dec. 18, 2012 -- People who can't get their high blood pressure down with drugs may be helped by a new procedure that deactivates overactive nerves in the kidneys, a small study shows.

"Dec. 18, 2012 -- People who can't get their high blood pressure down with drugs may be helped by a new procedure that deactivates overactive nerves in the kidneys, a small study shows.


Slide 5. Eplere...

... Sustained R...

Back to article...

Diuretics Pharm...

Anatomy of the ...

Figure 3 Effect...

Casodex (Bicalu...

Diuretics at Un...

If patient is o...

LipitorNorvascZ...

Herzklappenfehl...

Take with Plent...

NEDITOL (Tolter...

recent advance ...

Clopidogrel Fil...

Kaliumsparende ...

Atorvastatin–...

Knochenstoffwec...

Commenti: 55 co...